| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |